Physician profile
Isaac E Lopez
NPI 1649761297
$6,960.65
in general payments reported to CMS, 2019-2025
39 companies · $1,883 in 2025
The $1,883 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $734 · 2022: $784 · 2023: $1,527 · 2024: $2,033 · 2025: $1,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,172 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,172.40 |
| Education | $270.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,330.36 | 2021-2025 | |
| Novo Nordisk INC | $958.70 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $884.39 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $573.08 | 2023-2025 | Veozah |
| Amgen INC. | $369.70 | 2021-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $350.75 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $343.63 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $231.59 | 2021-2025 | Airsupra, Farxiga |
| Pfizer INC. | $181.51 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $167.50 | 2024-2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $152.89 | 2022-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $140.80 | 2023-2025 | |
| Exact Sciences Corporation | $133.02 | 2023-2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $124.24 | 2024-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.18 | 2021-2025 | Xifaxan |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $92.13 | 2021-2024 | Freestyle Libre 3 |
| Viatris Specialty LLC | $86.28 | 2025 | Yupelri |
| Phathom Pharmaceuticals, INC. | $80.68 | 2024-2025 | Voquezna |
| Philips North America LLC | $78.39 | 2024-2025 | (O58) Sleep Respiratory Care Und, Respiratory |
| Novartis Pharmaceuticals Corporation | $78.37 | 2021-2023 | |
| Dexcom, INC. | $55.38 | 2024-2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $53.17 | 2022-2023 | Seglentis, Livalo |
| Phadia US INC. | $50.61 | 2024 | Immunocap |
| Sanofi-Aventis U.S. LLC | $40.27 | 2023 | |
| Baxter Healthcare | $29.05 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Lundbeck LLC | $26.93 | 2025 | Rexulti |
| Averitas Pharma INC. | $26.76 | 2024 | Qutenza |
| Madrigal Pharmaceuticals | $23.12 | 2024 | Resmetirom |
| Xeris Pharmaceuticals, INC. | $20.58 | 2021 | |
| Ardelyx, INC. | $20.33 | 2025 | Ibsrela |
| Genentech USA, INC. | $19.57 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.06 | 2022 | |
| Acclarent, INC | $17.44 | 2021 | |
| Merck Sharp & Dohme LLC | $17.37 | 2022 | |
| Mylan Specialty L.P. | $16.38 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 | |
| Idorsia Pharmaceuticals US INC | $15.94 | 2023 | Quviviq |
| Radius Health, INC. | $14.21 | 2023 | Tymlos |
| Paratek Pharmaceuticals, INC. | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.